Current treatment practice of Guillain-Barré syndromeChristine Verboon, Jan Bürmann, Bart C. Jacobs et al.|Neurology|2019Cited by 88
An International Perspective on Preceding Infections in Guillain-Barré SyndromeSonja E. Leonhard, Soledad Monges, Annemiek A. van der Eijk et al.|Neurology|2022Cited by 85
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré SyndromeHelle Al-Hakem, Fábio Barroso, Alex Y. Doets et al.|Neurology|2023Cited by 54
Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndromeRobin C.M. Thomma, Rhys Roberts, Susan K. Halstead et al.|Brain|2025Cited by 9
Neuromuscular transmission deficits in patients with <scp>CMT</scp> and <scp>ClC</scp>‐1 inhibition in <scp>CMT</scp> animal modelsThomas Skjærlund Grønnebæk, W. David Arnold, Helga Haahr‐Lillevang et al.|Annals of Clinical and Translational Neurology|2024Cited by 5